Click to watch the live stream and join the conversation. #PhRMA16

0 SHARES

0

0

1

94

0 SHARES

0

0

1

94

Medicines in Development

Explore the latest progress on medicines in development.

Featured Report

Each patient battling with a disease or managing a condition lives in the hope that tomorrow will bring a new medicine that delivers better health. America’s biopharmaceutical research companies share the same goal of developing new medicines that can prevent diseases, improve patients’ health, and save lives. Beyond each individual patient, new drugs can help society overall by reducing sick days and helping cut the cost of healthcare.

Alzheimer's

There are more than five million Americans living with Alzheimer’s today. For patients with Alzheimer’s and other dementia, America’s biopharmaceutical research companies are developing medicines to bring us closer to our goal of tackling and eventually conquering this debilitating disease.

Arthritis

Nearly 100 medicines are in development for one of the most common chronic health problems in the U.S.

Asthma

Biopharmaceutical research companies are studying more than 70 medicines for asthma

Autoimmune Disease

Today, more than 80 autoimmune diseases have been identified. Many more diseases are thought to be autoimmune but have not been scientifically identified as such, and others are considered to be autoimmune-related conditions.

Biologics

Biologics research pushing frontiers of science with more than 900 medicines and vaccines in development

Cancer

America’s biopharmaceutical research companies are currently developing more than 800 medicines for cancer

Children

America’s biopharmaceutical companies are developing new medicines to help meet the unique health care needs of children and adolescents. Considerable progress in the fight against diseases that impact children has been achieved in recent decades, with medicines playing a key role.

COPD

Biopharmaceutical research companies are working on 54 medicines to treat chronic obstructive pulmonary disease

Diabetes

America’s biopharmaceutical research companies are currently developing more than 170 innovative new medicines to help the more than 30 million Americans affected by diabetes

Heart Disease and Stroke

America’s biopharmaceutical research companies are developing nearly 200 medicines for heart disease and stroke.

HIV/AIDS

Biopharmaceutical research companies are focusing on improved treatment regimens, more effective therapies and promising new preventative solutions.

Infectious Disease

Throughout history, infectious diseases have taken a devastating toll on the lives and well-being of people around the world.

Leukemia & Lymphoma

Each year more than 162,000 Americans are diagnosed with a blood cancer—accounting for more than 9 percent of all new cancer diagnoses.

Mental Health

Mental health conditions exact a heavy human and economic toll in the United States. The National Institute of Mental Health (NIMH) estimates that 1 in 4 American adults—61.5 million—have been diagnosed with a mental health disorder.

Neurological Disorders

Biopharmaceutical research companies are developing 444 new medicines to prevent and treat neurological disorders.

New Drug Approvals

In 2015, the Food and Drug Administration (FDA) approved a total of 57 new drugs and therapeutic biologics. Of those, a record 45 medicines were approved by the Center for Drug Evaluation and Research (CDER), while 12 biologics were approved by the Center for Biologics Evaluation and Research (CBER). The new medicines approved by the FDA in 2015 demonstrate the tireless work of America’s biopharmaceutical researchers and scientists to deliver on the promise of science.

Older Americans

With the population of Americans over 65 on the rise and life expectancy climbing, chronic diseases remain a principal threat to the health and productivity of older Americans, as well as to rising health care costs.

Osteoporosis

Nearly 54 million adults in the United States have either osteoporosis or low bone density, according to the National Osteoporosis Foundation. Today, biopharmaceutical research companies are developing nine medicines for the treatment of osteoporosis.

Parkinson's Disease

America’s biopharmaceutical research companies are currently developing 37 medicines to help the estimated 1.5 million Americans living with Parkinson’s disease.

Rare Diseases

The National Institutes of Health estimates that there are approximately 7,000 rare diseases affecting 30 million Americans.

Skin Diseases

America’s biopharmaceutical research companies currently are developing 277 medicines to help the more than 100 million Americans, one third of the U.S. population, that suffer from at least one skin disease.

Vaccines

For many years, vaccines have been used to successfully prevent devastating infectious diseases such as smallpox, measles and polio.

Women

Pharmaceutical researchers are developing more than 800 medicines for diseases that disproportionately affect women.

connect with PhRMA...

Make your voice heard. Join the important discussion on the value and economic impact of new medicines.


connect with PhRMA...

Make your voice heard. Join the important discussion on the value and economic impact of new medicines.


  • +68K

    Followers

  • +43K

    Followers

  • 378

    Followers

  • 1523

    Subscribers